Immunic Net Income vs Total Operating Expenses Analysis

IMUX Stock  USD 1.11  0.02  1.77%   
Immunic financial indicator trend analysis is infinitely more than just investigating Immunic recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Immunic is a good investment. Please check the relationship between Immunic Net Income and its Total Operating Expenses accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immunic. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
For more information on how to buy Immunic Stock please use our How to Invest in Immunic guide.

Net Income vs Total Operating Expenses

Net Income vs Total Operating Expenses Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Immunic Net Income account and Total Operating Expenses. At this time, the significance of the direction appears to have pay attention.
The correlation between Immunic's Net Income and Total Operating Expenses is -0.89. Overlapping area represents the amount of variation of Net Income that can explain the historical movement of Total Operating Expenses in the same time period over historical financial statements of Immunic, assuming nothing else is changed. The correlation between historical values of Immunic's Net Income and Total Operating Expenses is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Income of Immunic are associated (or correlated) with its Total Operating Expenses. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Operating Expenses has no effect on the direction of Net Income i.e., Immunic's Net Income and Total Operating Expenses go up and down completely randomly.

Correlation Coefficient

-0.89
Relationship DirectionNegative 
Relationship StrengthSignificant

Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in Immunic financial statement analysis. It represents the amount of money remaining after all of Immunic operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.
Most indicators from Immunic's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Immunic current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immunic. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
For more information on how to buy Immunic Stock please use our How to Invest in Immunic guide.Selling General Administrative is likely to drop to about 14 M in 2024. Issuance Of Capital Stock is likely to drop to about 810.4 K in 2024
 2021 2022 2023 2024 (projected)
Net Interest Income66K1.0M3.1M3.2M
Interest Income66K1.0M3.1M3.2M

Immunic fundamental ratios Correlations

0.310.320.390.960.21-0.95-0.040.570.960.60.960.41-0.620.70.33-0.530.210.97-0.23-0.48-0.530.280.280.340.05
0.310.620.690.21-0.04-0.31-0.580.20.34-0.160.370.82-0.220.40.560.05-0.040.39-0.030.06-0.450.560.560.47-0.51
0.320.620.970.220.23-0.33-0.620.430.4-0.190.390.82-0.450.320.46-0.090.230.4-0.2-0.43-0.470.640.650.3-0.57
0.390.690.970.270.09-0.34-0.60.390.410.00.40.91-0.460.420.45-0.080.090.42-0.07-0.42-0.560.570.580.31-0.46
0.960.210.220.270.28-0.94-0.040.550.930.590.920.26-0.750.640.38-0.730.280.93-0.14-0.6-0.550.330.320.180.03
0.21-0.040.230.090.28-0.430.060.670.42-0.380.41-0.19-0.34-0.150.04-0.351.00.37-0.58-0.320.240.190.190.17-0.11
-0.95-0.31-0.33-0.34-0.94-0.430.03-0.68-0.99-0.39-0.99-0.290.63-0.55-0.340.56-0.43-0.980.340.490.44-0.36-0.36-0.360.05
-0.04-0.58-0.62-0.6-0.040.060.030.13-0.070.24-0.07-0.640.4-0.23-0.880.190.06-0.09-0.150.30.64-0.83-0.840.120.86
0.570.20.430.390.550.67-0.680.130.690.030.670.21-0.440.2-0.03-0.330.670.65-0.33-0.41-0.180.240.240.30.01
0.960.340.40.410.930.42-0.99-0.070.690.380.990.36-0.640.550.35-0.540.420.99-0.34-0.5-0.470.380.380.36-0.08
0.6-0.16-0.190.00.59-0.38-0.390.240.030.380.350.12-0.270.570.02-0.3-0.380.390.27-0.33-0.43-0.19-0.2-0.030.53
0.960.370.390.40.920.41-0.99-0.070.670.990.350.37-0.630.560.35-0.530.411.0-0.36-0.44-0.450.370.370.38-0.09
0.410.820.820.910.26-0.19-0.29-0.640.210.360.120.37-0.330.580.530.03-0.190.40.03-0.2-0.620.510.520.39-0.43
-0.62-0.22-0.45-0.46-0.75-0.340.630.4-0.44-0.64-0.27-0.63-0.33-0.38-0.550.92-0.34-0.63-0.120.870.67-0.56-0.570.20.32
0.70.40.320.420.64-0.15-0.55-0.230.20.550.570.560.58-0.380.44-0.25-0.150.63-0.09-0.26-0.50.310.310.34-0.11
0.330.560.460.450.380.04-0.34-0.88-0.030.350.020.350.53-0.550.44-0.420.040.380.04-0.39-0.70.860.860.0-0.73
-0.530.05-0.09-0.08-0.73-0.350.560.19-0.33-0.54-0.3-0.530.030.92-0.25-0.42-0.35-0.52-0.160.790.51-0.39-0.380.360.16
0.21-0.040.230.090.281.0-0.430.060.670.42-0.380.41-0.19-0.34-0.150.04-0.350.37-0.58-0.320.240.190.190.17-0.11
0.970.390.40.420.930.37-0.98-0.090.650.990.391.00.4-0.630.630.38-0.520.37-0.35-0.45-0.470.370.380.4-0.09
-0.23-0.03-0.2-0.07-0.14-0.580.34-0.15-0.33-0.340.27-0.360.03-0.12-0.090.04-0.16-0.58-0.35-0.17-0.430.050.06-0.68-0.04
-0.480.06-0.43-0.42-0.6-0.320.490.3-0.41-0.5-0.33-0.44-0.20.87-0.26-0.390.79-0.32-0.45-0.170.59-0.45-0.450.30.18
-0.53-0.45-0.47-0.56-0.550.240.440.64-0.18-0.47-0.43-0.45-0.620.67-0.5-0.70.510.24-0.47-0.430.59-0.68-0.690.240.45
0.280.560.640.570.330.19-0.36-0.830.240.38-0.190.370.51-0.560.310.86-0.390.190.370.05-0.45-0.681.0-0.08-0.87
0.280.560.650.580.320.19-0.36-0.840.240.38-0.20.370.52-0.570.310.86-0.380.190.380.06-0.45-0.691.0-0.08-0.87
0.340.470.30.310.180.17-0.360.120.30.36-0.030.380.390.20.340.00.360.170.4-0.680.30.24-0.08-0.080.15
0.05-0.51-0.57-0.460.03-0.110.050.860.01-0.080.53-0.09-0.430.32-0.11-0.730.16-0.11-0.09-0.040.180.45-0.87-0.870.15
Click cells to compare fundamentals

Immunic Account Relationship Matchups

Immunic fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets66.0M167.9M139.1M127.8M54.3M81.3M
Other Current Liab343K4.4M7.2M8.2M18.9M19.9M
Total Current Liabilities7.1M8.4M11.4M13.1M24.7M26.0M
Total Stockholder Equity58.4M158.8M127.1M113.7M28.9M27.5M
Property Plant And Equipment Net713K1.1M1.1M1.8M1.8M1.4M
Net Debt(28.8M)(126.8M)(86.3M)(105.2M)(45.3M)(47.6M)
Retained Earnings(59.9M)(103.9M)(196.9M)(317.3M)(410.9M)(390.3M)
Accounts Payable2.4M3.7M3.7M4.3M5.1M3.9M
Cash29.4M127.5M86.9M106.7M46.7M64.0M
Non Current Assets Total33.7M34.1M34.1M1.9M1.8M1.7M
Cash And Short Term Investments29.4M127.5M86.9M116.4M46.7M66.0M
Common Stock Shares Outstanding7.7M15.7M23.7M31.8M44.3M46.5M
Liabilities And Stockholders Equity66.0M167.9M139.1M127.8M54.3M81.3M
Non Current Liabilities Total520K679K584K992K639K607.1K
Other Current Assets2.9M6.3M18.1M9.5M5.9M4.6M
Other Stockholder Equity53.7M266.8M324.2M427.9M436.1M245.3M
Total Liab7.6M9.1M12.0M14.1M25.4M26.6M
Property Plant And Equipment Gross713K1.1M1.1M1.8M1.8M1.4M
Total Current Assets32.2M133.7M105.0M125.9M52.5M70.8M
Accumulated Other Comprehensive Income(1.4M)(4.1M)(252K)3.0M3.8M3.9M
Non Currrent Assets Other108K37K42K43K38.7K36.8K
Net Tangible Assets25.4M125.8M94.1M113.7M130.7M80.6M
Retained Earnings Total Equity(59.9M)(103.9M)(196.9M)(317.3M)(285.6M)(299.8M)
Capital Surpluse119.6M266.8M324.2M427.9M492.1M326.3M
Non Current Liabilities Other520K679K584K992K1.1M1.2M
Property Plant Equipment80K203K1.1M294K264.6K251.4K
Other Assets37K42K943K43K49.5K47.0K
Net Receivables408K1.6M2.2M2.7M703K1.3M
Net Invested Capital58.4M158.8M127.1M113.7M28.9M27.5M
Net Working Capital25.2M125.3M93.6M112.8M27.8M26.4M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Immunic Stock Analysis

When running Immunic's price analysis, check to measure Immunic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunic is operating at the current time. Most of Immunic's value examination focuses on studying past and present price action to predict the probability of Immunic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunic's price. Additionally, you may evaluate how the addition of Immunic to your portfolios can decrease your overall portfolio volatility.